830346-48-0 (1-(2-氟-6-(三氟甲基)苄基)-5-溴-6-甲基嘧啶-2,4(1H,3H) - 二酮 5-(2-氟-3-甲氧苯基)- 1 - [ [ 2-氟-6 -(三氟甲基)苯基]甲基] - 6-甲基-2,4,5-bromo-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione)

CAS号:
830346-48-0
中文名称:
1-(2-氟-6-(三氟甲基)苄基)-5-溴-6-甲基嘧啶-2,4(1H,3H) - 二酮 5-(2-氟-3-甲氧苯基)- 1 - [ [ 2-氟-6 -(三氟甲基)苯基]甲基] - 6-甲基-2,4
英文名称:
5-bromo-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione
分子式:
C13H9BrF4N2O2
分子量:
381.120376348495

1-(2-氟-6-(三氟甲基)苄基)-5-溴-6-甲基嘧啶-2,4(1H,3H) - 二酮 5-(2-氟-3-甲氧苯基)- 1 - [ [ 2-氟-6 -(三氟甲基)苯基]甲基] - 6-甲基-2,4(830346-48-0)名称与标识符

名称

中文别名:
5-溴-1-(2-氟-6-(三氟甲基)苄基)-4-羟基-6-甲基嘧啶-2(1H)-酮;5-溴-1-[2-氟-6-(三氟甲基)苄基]-6-甲基嘧啶-2,4(1H,3H)-二酮;英文名称:5-BROMO-1-(2-FLUORO-6-TRIFLUOROMETHYL-BENZYL)-6-METHYL-1H-PYRIMIDINE-2,4-DIONE;1-(2-氟-6-(三氟甲基)苄基)-5-溴-6-甲基嘧啶-2,4(1H,3H) - 二酮;1-(2-氟-6-(三氟甲基)苄基)-5-溴-6-甲基嘧啶-2,4(1H,3H) - 二酮 5-(2-氟-3-甲氧苯基)- 1 - [ [ 2-氟-6 -(三氟甲基)苯基]甲基] - 6-甲基-2,4;
英文别名:
2,4(1H,3H)-Pyrimidinedione,5-bromo-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-;5-BROMO-1-(2-FLUORO-6-TRIFLUOROMETHYL-BENZYL)-6-METHYL-1H-PYRIMIDINE-2,4-DIONE;5-bromo-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione;5-bromo-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione;5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione;5-bromo-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione;5-bromo-1-(2-fluoro-6-(trifluoromethyl)benzyl)-4-hydroxy-6-methylpyrimidin-2(1H)-one;5-Bromo-1-(2-fluoro-6-trifluoromethylbenzy;5-Bromo-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione (ACI);1-[2-Fluoro-6-(trifluoromethyl)benzyl]-5-bromo-6-methyl-1H-pyrimidine-2,4-dione;AS-36700;SB17979;5-Bromo-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione; 1-[2-Fluoro-6-(trifluoromethyl)benzyl]-5-bromo-6-methyl-1H-pyrimidine-2,4-dione;2,4(1H,3H)-Pyrimidinedione, 5-bromo-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-;K6ZVL4B7JA;MFCD12546646;5-Bromo-1-(2-fluoro-6-trifluoromethylbenzyl)-6-methyl-1H-pyrimidine-2,4-dione;830346-48-0;SCHEMBL1740707;5-Bromo-1-([2-fluoro-6-(trifluoromethyl)phenyl]methyl)-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione;5-Bromo-1-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione;AKOS025404694;DS-016951;C13H9BrF4N2O2;SY099629;AC-31343;5-bromo-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2.4(1H,3H)-dione;Elagolix Impurity 8;CS-0050652;UNII-K6ZVL4B7JA;2,4(1H,3H)-Pyrimidinedione, 5-bromo-1-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-6-methyl-;

标识符

MDL:
MFCD12546646
InChIKey:
RDQPTRWUBKZZFJ-UHFFFAOYSA-N
Inchi:
1S/C13H9BrF4N2O2/c1-6-10(14)11(21)19-12(22)20(6)5-7-8(13(16,17)18)3-2-4-9(7)15/h2-4H,5H2,1H3,(H,19,21,22)
SMILES:
O=C1C(Br)=C(C)N(CC2C(C(F)(F)F)=CC=CC=2F)C(=O)N1

1-(2-氟-6-(三氟甲基)苄基)-5-溴-6-甲基嘧啶-2,4(1H,3H) - 二酮 5-(2-氟-3-甲氧苯基)- 1 - [ [ 2-氟-6 -(三氟甲基)苯基]甲基] - 6-甲基-2,4(830346-48-0)物化性质

实验特性

  • LogP : 3.22600
  • PSA : 55.12000

计算特性

  • 精确分子量 : 379.97800
  • 氢键供体数量 : 1
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 2
  • 同位素质量 : 379.97835 g/mol
  • 重原子数量 : 22
  • 复杂度 : 521
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3
  • 拓扑分子极性表面积 : 49.4
  • 分子量 : 381.12

1-(2-氟-6-(三氟甲基)苄基)-5-溴-6-甲基嘧啶-2,4(1H,3H) - 二酮 5-(2-氟-3-甲氧苯基)- 1 - [ [ 2-氟-6 -(三氟甲基)苯基]甲基] - 6-甲基-2,4(830346-48-0)安全信息

1-(2-氟-6-(三氟甲基)苄基)-5-溴-6-甲基嘧啶-2,4(1H,3H) - 二酮 5-(2-氟-3-甲氧苯基)- 1 - [ [ 2-氟-6 -(三氟甲基)苯基]甲基] - 6-甲基-2,4(830346-48-0)推荐厂家 更多厂家(36)

1-(2-氟-6-(三氟甲基)苄基)-5-溴-6-甲基嘧啶-2,4(1H,3H) - 二酮 5-(2-氟-3-甲氧苯基)- 1 - [ [ 2-氟-6 -(三氟甲基)苯基]甲基] - 6-甲基-2,4(830346-48-0)合成路线

合成路线:1 步
反应条件:
参考文献:
Discovery of Sodium R-(+)-4-{2-[5-(2-Fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (Elagolix), a Potent and Orally Available Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor
Chen, Chen; et al, Journal of Medicinal Chemistry, 2008, 51(23), 7478-7485
合成路线:1 步
反应条件:
参考文献:
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
Ciceri, Samuele ; et al, Molecules, 2023, 28(9),
合成路线:2 步
反应条件:
参考文献:
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
Ciceri, Samuele ; et al, Molecules, 2023, 28(9),
合成路线:2 步
反应条件:
参考文献:
Discovery of Sodium R-(+)-4-{2-[5-(2-Fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (Elagolix), a Potent and Orally Available Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor
Chen, Chen; et al, Journal of Medicinal Chemistry, 2008, 51(23), 7478-7485
合成路线:3 步
反应条件:
参考文献:
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
Ciceri, Samuele ; et al, Molecules, 2023, 28(9),
合成路线:4 步
反应条件:
参考文献:
Discovery of Sodium R-(+)-4-{2-[5-(2-Fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (Elagolix), a Potent and Orally Available Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor
Chen, Chen; et al, Journal of Medicinal Chemistry, 2008, 51(23), 7478-7485
问答